Shirley Heather Wray, M.B.Ch.B., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Supranuclear Palsy, Progressive | 1 | 2021 | 80 | 0.750 |
Why?
|
| Strabismus | 1 | 2021 | 317 | 0.560 |
Why?
|
| Nystagmus, Pathologic | 2 | 2011 | 105 | 0.450 |
Why?
|
| Vision Disorders | 3 | 2016 | 1084 | 0.400 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2011 | 24 | 0.390 |
Why?
|
| Ocular Motility Disorders | 1 | 2011 | 144 | 0.350 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2011 | 155 | 0.340 |
Why?
|
| Optic Neuritis | 5 | 1995 | 174 | 0.310 |
Why?
|
| Ophthalmology | 1 | 2013 | 549 | 0.280 |
Why?
|
| Neurology | 1 | 2013 | 778 | 0.250 |
Why?
|
| Tegmentum Mesencephali | 2 | 2021 | 59 | 0.220 |
Why?
|
| Optic Nerve | 3 | 2016 | 567 | 0.200 |
Why?
|
| Evoked Potentials, Visual | 3 | 1992 | 415 | 0.180 |
Why?
|
| Carcinoma | 1 | 2011 | 2330 | 0.170 |
Why?
|
| Mesencephalon | 1 | 2021 | 332 | 0.170 |
Why?
|
| Atrophy | 2 | 2021 | 1627 | 0.160 |
Why?
|
| Tropicamide | 1 | 1997 | 22 | 0.150 |
Why?
|
| Myosin Light Chains | 1 | 1997 | 121 | 0.140 |
Why?
|
| Dystonia | 1 | 2020 | 366 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 2 | 2011 | 5349 | 0.140 |
Why?
|
| Pupil | 1 | 1997 | 142 | 0.140 |
Why?
|
| Visual Cortex | 2 | 2002 | 1089 | 0.140 |
Why?
|
| Perceptual Disorders | 1 | 1998 | 197 | 0.130 |
Why?
|
| Migraine Disorders | 2 | 2002 | 1694 | 0.130 |
Why?
|
| Mitochondrial Myopathies | 1 | 1995 | 49 | 0.120 |
Why?
|
| Prednisolone | 1 | 1995 | 326 | 0.110 |
Why?
|
| Methylprednisolone | 1 | 1995 | 384 | 0.110 |
Why?
|
| Electroretinography | 2 | 1992 | 517 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 1997 | 924 | 0.110 |
Why?
|
| Retinal Artery Occlusion | 1 | 1993 | 77 | 0.100 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2002 | 1469 | 0.100 |
Why?
|
| Optic Disk Drusen | 1 | 1992 | 38 | 0.100 |
Why?
|
| Infarction | 1 | 1993 | 247 | 0.100 |
Why?
|
| Bees | 1 | 1991 | 45 | 0.090 |
Why?
|
| Insect Bites and Stings | 1 | 1991 | 70 | 0.090 |
Why?
|
| Blindness | 1 | 1993 | 582 | 0.080 |
Why?
|
| Ophthalmoplegia, Chronic Progressive External | 2 | 2020 | 17 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 1992 | 342 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2013 | 1573 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 2011 | 1607 | 0.070 |
Why?
|
| Visual Perception | 1 | 1995 | 1374 | 0.070 |
Why?
|
| Emergencies | 1 | 1993 | 1209 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2021 | 36284 | 0.070 |
Why?
|
| Gonadotropin-Releasing Hormone | 3 | 1997 | 1153 | 0.070 |
Why?
|
| Multiple Sclerosis | 4 | 1995 | 3204 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2772 | 0.060 |
Why?
|
| Ischemia | 1 | 1993 | 1863 | 0.060 |
Why?
|
| Calcium | 1 | 1997 | 5721 | 0.060 |
Why?
|
| Hypothalamus | 3 | 1997 | 998 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2011 | 2118 | 0.050 |
Why?
|
| Phosphenes | 1 | 2002 | 41 | 0.050 |
Why?
|
| Humans | 24 | 2021 | 758406 | 0.050 |
Why?
|
| Brain | 4 | 1995 | 26947 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 2 | 1998 | 810 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2020 | 315 | 0.040 |
Why?
|
| Photic Stimulation | 2 | 1998 | 1967 | 0.040 |
Why?
|
| Reaction Time | 2 | 1998 | 2075 | 0.040 |
Why?
|
| Visual Fields | 3 | 1995 | 1054 | 0.040 |
Why?
|
| Aged | 11 | 2011 | 168218 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 2 | 1995 | 1475 | 0.040 |
Why?
|
| Neurons | 3 | 2011 | 9416 | 0.040 |
Why?
|
| Dinoprost | 1 | 1997 | 138 | 0.030 |
Why?
|
| Cyanides | 1 | 1997 | 82 | 0.030 |
Why?
|
| Oxytocics | 1 | 1997 | 65 | 0.030 |
Why?
|
| Female | 17 | 2020 | 390323 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 1997 | 8544 | 0.030 |
Why?
|
| Blepharoptosis | 2 | 1993 | 143 | 0.030 |
Why?
|
| Ophthalmoplegia | 2 | 1993 | 168 | 0.030 |
Why?
|
| Kearns-Sayre Syndrome | 1 | 1995 | 6 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2020 | 1387 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 1997 | 495 | 0.030 |
Why?
|
| Respirovirus | 1 | 1974 | 31 | 0.030 |
Why?
|
| Measles virus | 1 | 1974 | 67 | 0.030 |
Why?
|
| Brain Damage, Chronic | 1 | 1995 | 267 | 0.030 |
Why?
|
| Stroke | 1 | 2016 | 9694 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3262 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2002 | 6234 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1844 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 1998 | 849 | 0.030 |
Why?
|
| Antibodies, Viral | 2 | 1974 | 3142 | 0.030 |
Why?
|
| Potassium | 1 | 1997 | 1310 | 0.030 |
Why?
|
| Adult | 11 | 2020 | 219935 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 80168 | 0.030 |
Why?
|
| Pharyngeal Diseases | 1 | 1993 | 134 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1997 | 1197 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 1997 | 1090 | 0.020 |
Why?
|
| Middle Aged | 12 | 2002 | 219568 | 0.020 |
Why?
|
| Visual Acuity | 2 | 1992 | 2642 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1504 | 0.020 |
Why?
|
| Vision Tests | 1 | 1992 | 158 | 0.020 |
Why?
|
| Muscular Dystrophies | 1 | 1993 | 389 | 0.020 |
Why?
|
| Neural Conduction | 1 | 1992 | 441 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 1992 | 377 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 1997 | 12951 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1991 | 617 | 0.020 |
Why?
|
| Fundus Oculi | 1 | 1991 | 540 | 0.020 |
Why?
|
| Optic Chiasm | 1 | 1989 | 91 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 1995 | 1436 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 1993 | 407 | 0.020 |
Why?
|
| Skull Neoplasms | 1 | 1989 | 173 | 0.020 |
Why?
|
| Prospective Studies | 3 | 2002 | 54137 | 0.020 |
Why?
|
| Estrogens | 1 | 1994 | 1520 | 0.020 |
Why?
|
| Cerebellum | 1 | 1995 | 1497 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 1993 | 1044 | 0.020 |
Why?
|
| Male | 14 | 1998 | 358747 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1993 | 708 | 0.020 |
Why?
|
| Prednisone | 1 | 1991 | 1565 | 0.020 |
Why?
|
| Phosphorylation | 1 | 1997 | 8297 | 0.020 |
Why?
|
| Blood Physiological Phenomena | 1 | 1985 | 53 | 0.020 |
Why?
|
| Adolescent | 5 | 2002 | 87892 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1995 | 2731 | 0.020 |
Why?
|
| Hemagglutination Inhibition Tests | 2 | 1974 | 85 | 0.010 |
Why?
|
| Pattern Recognition, Automated | 1 | 1991 | 994 | 0.010 |
Why?
|
| Phenotype | 2 | 2020 | 16534 | 0.010 |
Why?
|
| Protons | 1 | 1989 | 1112 | 0.010 |
Why?
|
| Rats | 2 | 1997 | 23679 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1997 | 12262 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 1996 | 11892 | 0.010 |
Why?
|
| Acute Disease | 1 | 1991 | 7225 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1995 | 6570 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 5759 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1995 | 10146 | 0.010 |
Why?
|
| Disease Progression | 1 | 1995 | 13468 | 0.010 |
Why?
|
| Animals | 5 | 1997 | 167768 | 0.010 |
Why?
|
| Castration | 1 | 1996 | 153 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 1998 | 58683 | 0.010 |
Why?
|
| Vitellogenins | 1 | 1994 | 21 | 0.010 |
Why?
|
| Trochlear Nerve | 1 | 1974 | 26 | 0.010 |
Why?
|
| Blood Volume | 1 | 1995 | 550 | 0.010 |
Why?
|
| Hemianopsia | 1 | 1995 | 121 | 0.010 |
Why?
|
| Oculomotor Nerve | 1 | 1974 | 72 | 0.010 |
Why?
|
| Child | 2 | 1992 | 79818 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 17617 | 0.010 |
Why?
|
| Mice, Transgenic | 2 | 1996 | 9518 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1997 | 1133 | 0.010 |
Why?
|
| Histocompatibility Antigens | 1 | 1974 | 467 | 0.010 |
Why?
|
| Prolactin | 1 | 1994 | 621 | 0.010 |
Why?
|
| Xenopus | 1 | 1994 | 717 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 1974 | 717 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 1974 | 728 | 0.010 |
Why?
|
| Prognosis | 1 | 1993 | 29557 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 1994 | 820 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1996 | 7590 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 1705 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 1997 | 12759 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1991 | 39059 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4169 | 0.010 |
Why?
|
| Muscles | 1 | 1993 | 1579 | 0.000 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 6068 | 0.000 |
Why?
|
| Deglutition Disorders | 1 | 1993 | 625 | 0.000 |
Why?
|
| Chondrosarcoma | 1 | 1989 | 296 | 0.000 |
Why?
|
| Receptors, Estrogen | 1 | 1994 | 2210 | 0.000 |
Why?
|
| Chordoma | 1 | 1989 | 346 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 13447 | 0.000 |
Why?
|
| Pedigree | 1 | 1993 | 4578 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1996 | 5779 | 0.000 |
Why?
|
| Mice | 3 | 1997 | 81101 | 0.000 |
Why?
|
| Testosterone | 1 | 1994 | 2471 | 0.000 |
Why?
|
| Base Sequence | 1 | 1994 | 12436 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1997 | 18940 | 0.000 |
Why?
|
| Cell Line | 1 | 1994 | 15591 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1995 | 9267 | 0.000 |
Why?
|
| Age Factors | 1 | 1996 | 18358 | 0.000 |
Why?
|